Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for HRMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 58.12M
March 31, 2026 57.87M
December 31, 2025 57.73M
September 30, 2025 57.60M
June 30, 2025 57.54M
March 31, 2025 57.39M
December 31, 2024 57.14M
September 30, 2024 57.03M
June 30, 2024 56.83M
March 31, 2024 56.79M
December 31, 2023 56.77M
September 30, 2023 58.57M
June 30, 2023 60.00M
March 31, 2023 59.95M
December 31, 2022 59.62M
Date Value
September 30, 2022 59.30M
June 30, 2022 59.12M
March 31, 2022 59.03M
December 31, 2021 58.83M
September 30, 2021 58.41M
June 30, 2021 57.00M
March 31, 2021 56.89M
December 31, 2020 56.89M
September 30, 2020 56.89M
June 30, 2020 63.68M
March 31, 2020 63.68M
December 31, 2019 56.89M
September 30, 2019 56.89M
June 30, 2019 63.68M
March 31, 2019 63.68M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Liquidia Corp. 89.10M
Repligen Corp. 56.43M
Johnson & Johnson 2.408B
ACADIA Pharmaceuticals, Inc. 172.13M
ANI Pharmaceuticals, Inc. 22.97M